109
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Optimization of topical curcumin spanlastics for melanoma treatment

ORCID Icon, ORCID Icon & ORCID Icon
Pages 425-439 | Received 18 Jan 2023, Accepted 27 Mar 2023, Published online: 09 May 2023

References

  • Abdelrahman FE, Elsayed I, Gad MK, Elshafeey AH, Mohamed MI. 2017. Response surface optimization, ex vivo and in vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm. 530(1–2):1–11.
  • Agrawal R, Sandhu SK, Sharma I, Kaur IP. 2015. Development and evaluation of curcumin-loaded elastic vesicles as an effective topical anti-inflammatory formulation. AAPS PharmSciTech. 16(2):364–374.
  • Ahmad N, Ahmad R, Al-Qudaihi A, Alaseel SE, Fita IZ, Khalid MS, Pottoo FH. 2019. Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation. RSC Adv. 9(35):20192–20206.
  • Akbari J, Saeedi M, Enayatifard R, Morteza-Semnani K, Hashemi SMH, Babaei A, Rahimnia SM, Rostamkalaei SS, Nokhodchi A. 2020. Curcumin Niosomes (curcusomes) as an alternative to conventional vehicles: a potential for efficient dermal delivery. J Drug Delivery Sci Technol. 60:102035.
  • Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. 2010. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 79(3):330–338.
  • Apu AS, Pathan AH, Shrestha D, Kibria G, Jalil R. 2009. Investigation of in vitro release kinetics of carbamazepine from Eudragit® RS PO and RL PO matrix tablets. Trop J Pharm Res. 8(2):145–152.
  • Bakr MM, Shukr MH, ElMeshad AN. 2020. In situ hexosomal gel as a promising tool to ameliorate the transnasal brain delivery of vinpocetine: central composite optimization and in vivo biodistribution. J Pharm Sci. 109(7):2213–2223.
  • Bao H, Zhang Q, Xu H, Yan Z. 2016. Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies. Int J Nanomedicine. 11:929–940.
  • Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. 2007. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology. 5:3.
  • Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. 2012. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 17(5):5972–5987.
  • El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 397(1–2):164–172.
  • ElMeshad AN, Mohsen AM. 2016. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. 23(7):2115–2123.
  • Elsayed I, El-Dahmy RM, El-Emam SZ, Elshafeey AH, Abd El Gawad NA, El-Gazayerly ON. 2020. Response surface optimization of biocompatible elastic nanovesicles loaded with rosuvastatin calcium: enhanced bioavailability and anticancer efficacy. Drug Deliv Transl Res. 10(5):1459–1475.
  • Fahmy AM, El-Setouhy DA, Habib BA, Tayel SA. 2019. Enhancement of transdermal delivery of haloperidol via spanlastic dispersions: entrapment efficiency vs. particle size. AAPS PharmSciTech. 20(3):95.
  • Farghaly DA, Aboelwafa AA, Hamza MY, Mohamed MI. 2017. Topical delivery of fenoprofen calcium via elastic nano-vesicular spanlastics: optimization using experimental design and in vivo evaluation. AAPS PharmSciTech. 18(8):2898–2909.
  • Govender T, Stolnik S, Garnett M, Illum L, Davis S. 1999. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water-soluble drug. J Control Release. 57(2):171–185.
  • Hahn N, Eisen RJ, Eisen L, Lane RS. 2005. Ketamine-medetomidine anesthesia with atipamezole reversal: practical anesthesia for rodents under field conditions. Lab Anim. 34(2):48–51.
  • Hashim DM, Sheta NM, Elwazzan VS, Sakran W. 2019. Enhancing the sunscreen efficacy of bemotrizinol micropigment by using O/W nanoemulsion topical preparations. Int J Pharm Pharm Sci. 11(7):47–56.
  • Hatem S, Elkheshen SA, Kamel AO, Nasr M, Moftah NH, Ragai MH, Elezaby RS, El Hoffy NM. 2022. Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment. Drug Deliv. 29(1):1212–1231.
  • Hu L, Shi Y, Li JH, Gao N, Ji J, Niu F, Chen Q, Yang X, Wang S. 2015. Enhancement of oral bioavailability of curcumin by a novel solid dispersion system. AAPS PharmSciTech. 16(6):1327–1334.
  • Kakkar S, Kaur IP. 2011. Spanlastics—a novel nanovesicular carrier system for ocular delivery. Int J Pharm. 413(1–2):202–210.
  • Khan KA, Rhodes CT. 1972. Effect of compaction pressure on the efficiency of some direct compression systems. Pharm Acta Helv. 47(10):594–607.
  • Kntayya SB, Ibrahim MD, Ain NM, Iori R, Ioannides C, Razis AFA. 2018. Induction of apoptosis and cytotoxicity by isothiocyanate sulforaphene in human hepatocarcinoma HepG2 cells. Nutrients. 10(6):718.
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 15(1):25–35.
  • Li L, Ahmed B, Mehta K, Kurzrock R. 2007. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther. 6(4):1276–1282.
  • Liao W, Xiang W, Wang F, Wang R, Ding Y. 2017. Curcumin inhibited growth of human melanoma A375 cells via inciting oxidative stress. Biomed Pharmacother. 95:1177–1186.
  • Liu D, Chen Z. 2013. The effect of curcumin on breast cancer cells. J Breast Cancer. 16(2):133–137.
  • Lu H, Utama RH, Kitiyotsawat U, Babiuch K, Jiang Y, Stenzel MH. 2015. Enhanced transcellular penetration and drug delivery by crosslinked polymeric micelles into pancreatic multicellular tumor spheroids. Biomater Sci. 3(7):1085–1095.
  • Mazyed EA, Helal DA, Elkhoudary MM, Abd Elhameed AG, Yasser M. 2021. Formulation and optimization of nanospanlastics for improving the bioavailability of green tea epigallocatechin gallate. Pharmaceuticals. 14(1):68.
  • Mirzaei H, Naseri G, Rezaee R, Mohammadi M, Banikazemi Z, Mirzaei HR, Salehi H, Peyvandi M, Pawelek JM, Sahebkar A. 2016. Curcumin: a new candidate for melanoma therapy. Int J Cancer. 139(8):1683–1695.
  • Moore JW, Flanner HH. 1996, Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol. 20: 64–74.
  • Nair RS, Morris A, Billa N, Leong C. 2019. An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery. AAPS PharmSciTech. 20(2):69.
  • Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C. 2004. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer. 111(3):381–387.
  • Panigrahi S, Hirlekar R. 2016. A new stability-indicating RP-HPLC method for determination of curcumin: an application to the nanoparticulate formulation. Int J Pharm Pharm Sci. 8(12):149–155.
  • Patel NA, Patel NJ, Patel RP. 2009. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug. Drug Dev Ind Pharm. 35(2):234–242.
  • Pathan IB, Jaware BP, Shelke S, Ambekar W. 2018. Curcumin loaded ethosomes for transdermal application: formulation, optimization, in-vitro and in-vivo study. J Drug Deliv Sci Technol. 44:49–57.
  • Pillai O, Panchagnula R. 2003. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeateon studies in rat using iontophoresis and chemical enhancers. J Control Release. 89(1):127–140.
  • Rowe RC, Sheskey PJ, Owen SC. 2006. Handbook of pharmaceutical excipients. Fifth edition. Pharmaceutical Press and American Pharmacists Association. USA.
  • Saleh A, Khalifa M, Shawky S, Bani-Ali A, Eassa H. 2021. Zolmitriptan intranasal spanlastics for enhanced migraine treatment; formulation parameters optimized via quality by design approach. Sci Pharm. 89(2):24.
  • Shin GH, Li J, Cho JH, Kim JT, Park HJ. 2016. Enhancement of curcumin solubility by phase change from crystalline to amorphous in Cur-TPGS nanosuspension. J Food Sci. 81(2):N494–N501.
  • Tang H, Murphy CJ, Zhang B, Shen Y, Kirk EAV, Murdoch YJ, Radosz M. 2010. Curcumin polymers as anticancer conjugates. Biomaterial.s. 31(27):7139–7149.
  • Verma DD, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 258(1-2):141–151.
  • Williams AC, Timmins P, Lu M, Forbes RT. 2005. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers. Eur J Pharm Sci. 26(3–4):288–294.
  • Xu Y, Chen W, Tsosie JK, Xie X, Li P, Wan J, He C, Chen M. 2016. Niosome encapsulation of curcumin: characterization and cytotoxic effect on ovarian cancer cells. J Nanomater. 2016:1–9.
  • Zeng H, Li J, Hou K, Wu Y, Chen H, Ning Z. 2022. Melanoma and nanotechnology-based treatment. Front Oncol. 12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.